31 Results for "

MELK

" in MedChemExpress (MCE) Product Catalog:
Products (31)

31 Results for "MELK" in MCE Product Catalog:

  • Targets Recommended:
  • Recombinant Proteins Recommended:
37
37 Publications Verification
Cat. No.: HY-18174
CAS No.: 1234015-52-1
Synonyms: LY2606368
Research Areas:  

Cancer

Prexasertib (LY2606368) is a selective, ATP-competitive second-generation checkpoint kinase 1 (CHK1) inhibitor with a Ki of 0.9 nM and an IC50 of <1 nM. Prexasertib inhibits CHK2 (IC50=8 nM) and RSK1 (IC50=9 nM). Prexasertib causes double-stranded DNA breakage and replication catastrophe resulting in apoptosis. Prexasertib shows potent anti-tumor activity .
loading...
    loading...
37
37 Publications Verification
Cat. No.: HY-18174A
CAS No.: 1234015-54-3
Synonyms: LY2606368 dihydrochloride
Research Areas:  

Cancer

Prexasertib dihydrochloride (LY2606368 dihydrochloride) is a selective, ATP-competitive second-generation checkpoint kinase 1 (CHK1) inhibitor with a Ki of 0.9 nM and an IC50 of <1 nM. Prexasertib dihydrochloride inhibits CHK2 (IC50=8 nM) and RSK1 (IC50=9 nM). Prexasertib dihydrochloride causes double-stranded DNA breakage and replication catastrophe resulting in apoptosis. Prexasertib dihydrochloride shows potent anti-tumor activity .
loading...
    loading...
37
37 Publications Verification
Cat. No.: HY-18174E
CAS No.: 1234015-58-7
Synonyms: LY2606368 dimesylate
Research Areas:  

Cancer

Prexasertib dimesylate (LY2606368 dimesylate) is a selective, ATP-competitive second-generation checkpoint kinase 1 (CHK1) inhibitor with a Ki of 0.9 nM and an IC50 of <1 nM. Prexasertib dimesylate inhibits CHK2 (IC50=8 nM) and RSK1 (IC50=9 nM). Prexasertib dimesylate causes double-stranded DNA breakage and replication catastrophe resulting in apoptosis. Prexasertib dimesylate shows potent anti-tumor activity .
loading...
    loading...
23
23 Cited Publications
Cat. No.: HY-15512
CAS No.: 1431697-89-0
Purity:  99.70%
Synonyms: OTS167
Target:  

MELK

Research Areas:  

Cancer

OTSSP167 (OTS167) is a highly potent and ATP-competitive MELK inhibitor with IC50 value of 0.41 nM.
loading...
    loading...
23
23 Cited Publications
Cat. No.: HY-15512A
CAS No.: 1431698-10-0
Purity:  99.84%
Synonyms: OTS167 hydrochloride
Target:  

MELK

Research Areas:  

Cancer

OTSSP167 (OTS167) hydrochloride is a highly potent and ATP-competitive MELK inhibitor with IC50 value of 0.41 nM.
loading...
    loading...
3
3 Cited Publications
Cat. No.: HY-100368A
CAS No.: 2096992-20-8
Purity:  99.31%
Synonyms: NVS-MELK8a hydrochloride
Target:  

MELK

Research Areas:  

Cancer

MELK-8a hydrochloride is a novel maternal embryonic leucine zipper kinase (MELK) inhibitor with an IC50 of 2 nM.
loading...
    loading...
3
3 Cited Publications
Cat. No.: HY-100368
CAS No.: 1922153-17-0
Purity:  98.32%
Synonyms: NVS-MELK8a
Research Areas:  

Cancer

MELK-8a (NVS-MELK8a) is a highly potent and selective maternal embryonic leucine zipper kinase (MELK) inhibitor with IC50 of 2 nM. MELK-8a also inhibits Flt3 (ITD), Haspin, PDGFRα with IC50s of 0.18, 0.19, and 0.42 μM, respectively. MELK plays an essential role in regulating cell mitosis in a subset of cancer cells .
loading...
    loading...
Cat. No.: HY-148065
CAS No.: 2769753-07-1
Purity:  98.77%
FMF-06-098-1 is a multi-target kinase PROTAC degrader. FMF-06-098-1 can be used to target degradation kinases which degrades AAK1, AΒL2, AURKA, AURKB, BUBIB, CDC7, CDK1, CDK12, CDK13, CDK2, CDK4, CDk6, CDK7, CDK9, CHEK1, CSNKID, EPHA1, PER, FGFR1, GAK, IRAK4, ITK, LIMK2, MAP4K2, MAP4K3, MAPK6, MAPK7, MARK4, MELK, PKN3, PLK4, PRKAA1, PTK2, PTK6, RPS6KA4, S1K2, STK35, TNK2, UHMK1, ULK1, and WEE1 .
loading...
    loading...
Cat. No.: HY-101515
CAS No.: 2095596-44-2
Purity:  98.67%
Target:  

MELK

Research Areas:  

Cancer

MELK-IN-1 is a potent inhibitor of maternal embryonic leucine zipper kinase (MELK) with an IC50 and a Ki of 3 nM and 0.39 nM, respectively.
loading...
    loading...
Cat. No.: HY-122665
CAS No.: 2000209-42-5
Purity:  98.64%
Research Areas:  

Cancer

HTH-01-091 is a potent and selective maternal embryonic leucine zipper kinase (MELK) inhibitor, with an IC50 of 10.5 nM. HTH-01-091 also inhibits PIM1/2/3, RIPK2, DYRK3, smMLCK and CLK2. HTH-01-091 can be uesd for breast cancer research .
loading...
    loading...
Cat. No.: HY-12420
CAS No.: 1610536-69-0
Purity:  99.68%
Synonyms: MELK-T1 hydrochloride
Target:  

MELK FLT3

Research Areas:  

Cancer

JNJ-47117096 hydrochloride is potent and selective MELK inhibitor, with an IC50 of 23 nM, also effectively inhibits Flt3, with an IC50 of 18 nM.
loading...
    loading...
Cat. No.: HY-122665A
Purity:  98.01%
Research Areas:  

Cancer

HTH-01-091 TFA is a potent and selective maternal embryonic leucine zipper kinase (MELK) inhibitor, with an IC50 of 10.5 nM. HTH-01-091 TFA also inhibits PIM1/2/3, RIPK2, DYRK3, smMLCK and CLK2. HTH-01-091 TFA can be uesd for breast cancer research .
loading...
    loading...
Cat. No.: HY-18174H
CAS No.: 2781996-46-9
Synonyms: LY2606368 lactate
Research Areas:  

Cancer

Prexasertib lactate (LY2606368 lactate) is the lactate form of Prexasertib (HY-18174). Prexasertib lactate is a selective, ATP-competitive second-generation checkpoint kinase 1 (CHK1) inhibitor with a Ki of 0.9 nM and an IC50 of <1 nM. Prexasertib lactate inhibits CHK2 (IC50=8 nM) and RSK1 (IC50=9 nM). Prexasertib lactate causes double-stranded DNA breakage and replication catastrophe resulting in apoptosis. Prexasertib lactate shows potent anti-tumor activity .
loading...
    loading...
Cat. No.: HY-144869
CAS No.: 1356943-67-3
Purity:  99.83%
Target:  

FLT3

Research Areas:  

Cancer

OTS447 is a potent FLT3 inhibitor with an IC50 of 21 nM (WO2012016082A1, compound 335) .
loading...
    loading...
Cat. No.: HY-18174B
CAS No.: 1234015-57-6
Synonyms: LY2606368 Mesylate Hydrate; LY2940930
Research Areas:  

Cancer

Prexasertib Mesylate Hydrate (LY2606368 Mesylate Hydrate) is a selective, ATP-competitive second-generation checkpoint kinase 1 (CHK1) inhibitor with a Ki of 0.9 nM and an IC50 of <1 nM. Prexasertib Mesylate Hydrate inhibits CHK2 (IC50=8 nM) and RSK1 (IC50=9 nM). Prexasertib Mesylate Hydrate causes double-stranded DNA breakage and replication catastrophe resulting in apoptosis. Prexasertib Mesylate Hydrate shows potent anti-tumor activity .
loading...
    loading...
Cat. No.: HY-18174C
CAS No.: 1234015-55-4
Synonyms: LY2606368 mesylate
Research Areas:  

Cancer

Prexasertib mesylate (LY2606368 mesylate) is a selective, ATP-competitive second-generation checkpoint kinase 1 (CHK1) inhibitor with a Ki of 0.9 nM and an IC50 of <1 nM. Prexasertib mesylate inhibits CHK2 (IC50=8 nM) and RSK1 (IC50=9 nM). Prexasertib mesylate causes double-stranded DNA breakage and replication catastrophe resulting in apoptosis. Prexasertib mesylate shows potent anti-tumor activity .
loading...
    loading...
Cat. No.: HY-RS08328
Research Areas:  

Others

MELK Human Pre-designed siRNA Set A contains three designed siRNAs for MELK gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

loading...
    loading...
Cat. No.: HY-RS08329
Research Areas:  

Others

Melk Mouse Pre-designed siRNA Set A contains three designed siRNAs for Melk gene (Mouse), as well as a negative control, a positive control, and a FAM-labeled negative control.

loading...
    loading...
Cat. No.: HY-RS08330
Research Areas:  

Others

Melk Rat Pre-designed siRNA Set A contains three designed siRNAs for Melk gene (Rat), as well as a negative control, a positive control, and a FAM-labeled negative control.

loading...
    loading...
Cat. No.: HY-155748
Target:  

MELK Apoptosis

Research Areas:  

Cancer

Antitumor agent-116 (compound 6C) is an anti-tumor agent with anti-proliferative activities. Antitumor agent-11 induces cell apoptosis, and shows the binding affinity against the MELK receptor .
loading...
    loading...